Cytokinetics Inc (CYTK): Net Income
-$784.96M
Year ended 2025-12-31
-$894.00M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$784.96M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$589.53M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$526.24M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$388.95M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$215.31M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$127.29M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$121.69M | n/m | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | -$106.29M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$127.79M | n/m | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | $16.45M | n/m | 2018-03-05, From 2016-01-01 |
| 2015-12-31 | -$37.50M | n/m | 2018-03-05, From 2015-01-01 |
| 2014-12-31 | -$14.65M | n/m | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | -$33.72M | n/m | 2016-03-03, From 2013-01-01 |
| 2012-12-31 | -$40.37M | n/m | 2015-03-06, From 2012-01-01 |
| 2011-12-31 | -$47.86M | n/m | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | -$49.29M | n/m | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $24.54M | n/m | 2013-03-15, From 2009-01-01 |
| 2008-12-31 | -$56.37M | n/m | 2013-03-15, From 2008-01-01 |
| 2007-12-31 | -$48.89M | n/m | 2013-03-15, From 2007-01-01 |
| 2006-12-31 | -$57.12M | n/m | 2013-03-15, From 2006-01-01 |
| 2005-12-31 | -$42.25M | n/m | 2013-03-15, From 2005-01-01 |
| 2004-12-31 | -$37.20M | n/m | 2013-03-15, From 2004-01-01 |
| 2003-12-31 | -$32.69M | n/m | 2013-03-15, From 2003-01-01 |
| 2002-12-31 | -$23.08M | n/m | 2013-03-15, From 2002-01-01 |
| 2001-12-31 | -$15.87M | n/m | 2013-03-15, From 2001-01-01 |
| 2000-12-31 | -$13.08M | n/m | 2013-03-15, From 2000-01-01 |
| 1999-12-31 | -$7.34M | n/a | 2013-03-15, From 1999-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | 2025-12-31 | -$784.96M | n/m |
| Standard Biotools Inc. (LAB) | 2025-12-31 | -$74.90M | n/m |
| ARS Pharmaceuticals, Inc. (SPRY) | 2025-12-31 | -$171.30M | n/m |
| Nurix Therapeutics, Inc. (NRIX) | 2025-11-30 | -$264.46M | n/m |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | -$65.78M | n/m |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $23.28M | -60.7% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | -$142.62M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | -$4.60M | n/m |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$17.37M | n/m |
Compare CYTK, LAB, SPRY, NRIX side by side · Screen every company in Pharmaceutical Preparations ↗